Status: retired, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1766796014 | Erythromycin ethylsuccinate + sulfisoxazole acetyl (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 1773271017 | Erythromycin ethylsuccinate + sulphisoxazole acetyl | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 1774557015 | Erythromycin ethylsuccinate + sulfisoxazole acetyl | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3522656019 | Product containing erythromycin ethylsuccinate and sulfafurazole acetyl (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3522657011 | Erythromycin ethylsuccinate and sulfafurazole acetyl | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3522658018 | Erythromycin ethylsuccinate and sulfisoxazole acetyl | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3522659014 | Product containing erythromycin ethylsuccinate and sulfisoxazole acetyl | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3522660016 | Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3695107016 | Erythromycin ethyl succinate and sulfafurazole acetyl product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3695108014 | Erythromycin ethylsuccinate and sulfisoxazole acetyl product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Is a | Erythromycin-containing product | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Is a | Sulfafurazole-containing product | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Has active ingredient | Erythromycin ethylsuccinate | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Has active ingredient | Sulfisoxazole acetyl | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Is a | Erythromycin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Is a | Product containing erythromycin ethylsuccinate | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Is a | Sulfafurazole-containing product in oral dose form | false | Inferred relationship | Some | ||
| Erythromycin ethyl succinate and sulfafurazole acetyl product | Is a | Macrolide antibacterial agent | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | Is a | False | Erythromycin ethyl succinate and sulfafurazole acetyl product | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR